Marshall Wace
CAMP icon

Marshall Wace’s CAMP4 Therapeutics CAMP Stock Holding History

Marshall Wace’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62K Buy
+14,191
New +$61.2K ﹤0.01% 2975

Other funds holding CAMP

JT
Jupiter Topco New York $245B AUM
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace's CAMP Position: Q2 2026 in Review

Marshall Wace opened a new position in CAMP4 Therapeutics (CAMP) in Q2 2026: 14,191 shares worth $62K. The stake represents ﹤0.01% of the portfolio and ranks #2975 among its holdings.

61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Marshall Wace held 14,191 shares of CAMP4 Therapeutics worth $62K as of Q2 2026.
  • CAMP4 Therapeutics was a new Marshall Wace position in Q2 2026.
  • CAMP4 Therapeutics made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2975 holding.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.